LeMaitre Vascular, Inc. (LMAT): Price and Financial Metrics
GET POWR RATINGS... FREE!
LMAT POWR Grades
- LMAT scores best on the Quality dimension, with a Quality rank ahead of 91.21% of US stocks.
- LMAT's strongest trending metric is Value; it's been moving up over the last 177 days.
- LMAT's current lowest rank is in the Momentum metric (where it is better than 12.43% of US stocks).
LMAT Stock Summary
- LMAT's current price/earnings ratio is 47.72, which is higher than 87.11% of US stocks with positive earnings.
- Price to trailing twelve month operating cash flow for LMAT is currently 38.36, higher than 87.21% of US stocks with positive operating cash flow.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 1.15 for LEMAITRE VASCULAR INC; that's greater than it is for merely 11.33% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to LEMAITRE VASCULAR INC are GMED, CSPI, SHYF, MMSI, and INTT.
- LMAT's SEC filings can be seen here. And to visit LEMAITRE VASCULAR INC's official web site, go to www.lemaitre.com.
LMAT Valuation Summary
- LMAT's EV/EBIT ratio is 36.9; this is 272.73% higher than that of the median Healthcare stock.
- Over the past 198 months, LMAT's price/earnings ratio has gone up 263.
Below are key valuation metrics over time for LMAT.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
LMAT | 2023-01-20 | 6.5 | 4.0 | 49.0 | 36.9 |
LMAT | 2023-01-19 | 6.4 | 3.9 | 48.4 | 36.4 |
LMAT | 2023-01-18 | 6.1 | 3.8 | 46.5 | 35.0 |
LMAT | 2023-01-17 | 6.2 | 3.8 | 47.0 | 35.4 |
LMAT | 2023-01-13 | 6.3 | 3.9 | 47.9 | 36.1 |
LMAT | 2023-01-12 | 6.3 | 3.9 | 47.8 | 36.0 |
LMAT Growth Metrics
- The 2 year revenue growth rate now stands at 32.52%.
- Its 2 year price growth rate is now at 53.03%.
- Its 3 year net income to common stockholders growth rate is now at 19.52%.

The table below shows LMAT's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 160.2 | 26.357 | 21.184 |
2022-06-30 | 159.54 | 33.09 | 22.232 |
2022-03-31 | 158.102 | 33.739 | 27.016 |
2021-12-31 | 154.424 | 35.102 | 26.907 |
2021-09-30 | 152.469 | 44.198 | 27.765 |
2021-06-30 | 150.517 | 44.235 | 28.774 |
LMAT's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- LMAT has a Quality Grade of B, ranking ahead of 84.43% of graded US stocks.
- LMAT's asset turnover comes in at 0.589 -- ranking 73rd of 186 Medical Equipment stocks.
- ISRG, SYK, and KIDS are the stocks whose asset turnover ratios are most correlated with LMAT.
The table below shows LMAT's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-09-30 | 0.589 | 0.655 | 0.287 |
2021-06-30 | 0.597 | 0.649 | 0.299 |
2021-03-31 | 0.530 | 0.653 | 0.241 |
2020-12-31 | 0.542 | 0.654 | 0.220 |
2020-09-30 | 0.548 | 0.657 | 0.196 |
2020-06-30 | 0.574 | 0.677 | 0.177 |
LMAT Price Target
For more insight on analysts targets of LMAT, see our LMAT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $66.14 | Average Broker Recommendation | 1.5 (Moderate Buy) |
LMAT Stock Price Chart Interactive Chart >
LMAT Price/Volume Stats
Current price | $46.03 | 52-week high | $56.38 |
Prev. close | $45.88 | 52-week low | $38.32 |
Day low | $45.37 | Volume | 49,700 |
Day high | $46.86 | Avg. volume | 66,463 |
50-day MA | $45.98 | Dividend yield | 1.09% |
200-day MA | $47.09 | Market Cap | 1.01B |
LeMaitre Vascular, Inc. (LMAT) Company Bio
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease. The company was founded in 1983 and is based in Burlington, Massachusetts.
Latest LMAT News From Around the Web
Below are the latest news stories about LEMAITRE VASCULAR INC that investors may wish to consider to help them evaluate LMAT as an investment opportunity.
VREX vs. LMAT: Which Stock Is the Better Value Option?VREX vs. LMAT: Which Stock Is the Better Value Option? |
Is This Small-Cap Dividend Stock a Buy?LeMaitre Vascular isn't well-known to investors. But vascular surgeons do know the company well. |
ESLOY vs. LMAT: Which Stock Should Value Investors Buy Now?ESLOY vs. LMAT: Which Stock Is the Better Value Option? |
ESLOY or LMAT: Which Is the Better Value Stock Right Now?ESLOY vs. LMAT: Which Stock Is the Better Value Option? |
LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?LeMaitre Vascular (NASDAQ:LMAT) has had a rough three months with its share price down 8.3%. However, the company's... |
LMAT Price Returns
1-mo | 0.02% |
3-mo | 5.06% |
6-mo | -14.14% |
1-year | 9.95% |
3-year | 32.07% |
5-year | 37.15% |
YTD | 0.02% |
2022 | -7.40% |
2021 | 25.10% |
2020 | 14.09% |
2019 | 53.77% |
2018 | -25.13% |
LMAT Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Continue Researching LMAT
Here are a few links from around the web to help you further your research on Lemaitre Vascular Inc's stock as an investment opportunity:Lemaitre Vascular Inc (LMAT) Stock Price | Nasdaq
Lemaitre Vascular Inc (LMAT) Stock Quote, History and News - Yahoo Finance
Lemaitre Vascular Inc (LMAT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...